# Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers

> **NCT00448903** · PHASE3 · COMPLETED · sponsor: **Rovi Pharmaceuticals Laboratories** · enrollment: 329 (actual)

## Conditions studied

- Foot Ulcer, Diabetic

## Interventions

- **DRUG:** Bemiparin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00448903
- **Lead sponsor:** Rovi Pharmaceuticals Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-12
- **Final completion:** 2010-04
- **Target enrollment:** 329 (ACTUAL)
- **Last updated:** 2011-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00448903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00448903, "Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00448903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*